Stocks · Health care · Pharmaceutical Preparations

ANAPTYSBIO, INC

ANAB Clue Score43
United States Fiscal year ends June CIK 0001370053 Results filed 12 May 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Hollings Renton
1 Oct 2026
Director
Sold after exercise
5,000
$49.87
$249.37K
Eric J Loumeau
11 Feb 2026
Chief Legal Officer
Sold after exercise
10,000
$54.00
$540.00K
Magda Marquet
15 Jan 2026
Director
Sold after exercise
1,710
$48.85
$83.53K
Magda Marquet
15 Jan 2026
Director
Sold after exercise
9,290
$48.12
$447.00K
Eric J Loumeau
22 Dec 2025
Chief Legal Officer
Sold after exercise
10,000
$51.00
$510.00K
Dennis Mulroy
22 Dec 2025
Chief Financial Officer
Sold after exercise
10,000
$50.00
$500.00K
Paul F. Lizzul
22 Dec 2025
Chief Medical Officer
Sold after exercise
1,500
$50.00
$75.00K
Eric J Loumeau
17 Dec 2025
Chief Legal Officer
Sold after exercise
10,000
$46.00
$460.00K
Dennis Mulroy
16 Dec 2025
Chief Financial Officer
Sold after exercise
6,360
$45.21
$287.51K
Dennis Mulroy
16 Dec 2025
Chief Financial Officer
Sold after exercise
9,365
$44.62
$417.82K
Eric J Loumeau
16 Dec 2025
Chief Legal Officer
Sold after exercise
4,195
$45.24
$189.77K
Eric J Loumeau
16 Dec 2025
Chief Legal Officer
Sold after exercise
8,305
$44.68
$371.03K

What was left out

Form 4 filings counted 44
Amendments (4/A) skipped 1
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 12
Sales at will 29
Transactions with no price 0
Shares from compensation/vesting 288,305
History held since 31 Jan 2017